ResMed Inc (RMD)

NYSE
Currency in USD
239.78
+2.65(+1.12%)
Closed
After Hours
236.75-3.03(-1.26%)
RMD Scorecard
Full Analysis
Has raised its dividend for 13 consecutive years
Earnings results expected in 10 days
Fair Value
Day's Range
235.88240.37
52 wk Range
170.56260.49
Key Statistics
Edit
Prev. Close
237.13
Open
237.99
Day's Range
235.88-240.37
52 wk Range
170.56-260.49
Volume
776.86K
Average Volume (3m)
894.34K
1-Year Change
38.97%
Book Value / Share
35.36
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RMD Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
256.02
Upside
+6.77%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple
Show more

ResMed Inc Company Profile

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients’ device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN’s software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

ResMed Inc SWOT Analysis


Sleep Tech Dominance
ResMed's market leadership in sleep apnea and respiratory care devices faces challenges from emerging treatments and renewed competition
Financial Resilience
Explore ResMed's robust financial performance, with consistent revenue growth and strong earnings, despite looming market disruptions
Innovation Pipeline
Delve into ResMed's strategic expansion beyond CPAP, leveraging AI and wearable technology to diversify its product portfolio
Market Outlook
Analyst targets range from $180 to $250, reflecting varied perspectives on ResMed's ability to navigate pharmaceutical threats and maintain growth
Read full SWOT analysis

ResMed Inc Earnings Call Summary for Q1/2025

  • ResMed reports 11% revenue growth to $1.22B in Q1 FY2025, with 27% rise in operating profit and 35% increase in net income
  • Strong performance attributed to AirSense platforms; upcoming launch of AirTouch N30i mask expected to improve patient adherence
  • Company declares $0.53/share dividend, plans continued share buybacks, and aims to empower 500M people with health tech by 2030
  • ResMed leveraging digital health innovations to expand into markets like insomnia and COPD, with 20B nights of health data in the cloud
  • Strategic acquisitions and R&D focus to drive growth; company prepared for increased competition, particularly from Philips
Last Updated: 10/26/2024, 04:34 AM
Read Full Transcript

Compare RMD to Peers and Sector

Metrics to compare
RMD
Peers
Sector
Relationship
P/E Ratio
31.6x59.9x−0.6x
PEG Ratio
1.40−2.060.00
Price/Book
6.8x8.1x2.6x
Price / LTM Sales
7.3x11.2x3.1x
Upside (Analyst Target)
10.9%22.6%54.8%
Fair Value Upside
Unlock−25.0%7.9%Unlock

Analyst Ratings

9 Buy
8 Hold
1 Sell
Ratings:
18 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 256.02
(+6.77% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 7.57
Dividend Yield
0.88%
Industry Median 0.72%
Annualized payout
2.1200
Paid quarterly
5-Years Growth
+5.32%
Growth Streak

Earnings

Latest Release
Oct 24, 2024
EPS / Forecast
2.20 / 2.05
Revenue / Forecast
1.22B / 1.19B
EPS Revisions
Last 90 days

People Also Watch

429.03
MSFT
+1.05%
612.77
META
+0.24%
225.94
AMZN
+2.39%
237.44
AVGO
+3.50%
426.50
TSLA
+3.06%

FAQ

What Is the ResMed (RMD) Stock Price Today?

The ResMed stock price today is 239.78

What Stock Exchange Does ResMed Trade On?

ResMed is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for ResMed?

The stock symbol for ResMed is "RMD."

Does ResMed Pay Dividends? What’s The Current Dividend Yield?

The ResMed dividend yield is 0.88%.

What Is the ResMed Market Cap?

As of today, ResMed market cap is 35.21B.

What is ResMed Earnings Per Share?

The ResMed EPS is 7.57.

What Is the Next ResMed Earnings Date?

ResMed will release its next earnings report on Jan 29, 2025.

From a Technical Analysis Perspective, Is RMD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.